Global Drug Device Combination Products Market Size & Outlook

The drug device combination products industry worldwide is expected to reach a projected revenue of US$ 251,872.3 million by 2030. A compound annual growth rate of 8.9% is expected of the worldwide drug device combination products industry from 2024 to 2030.
Revenue, 2023 (US$M)
$138,476.4
Forecast, 2030 (US$M)
$251,872.3
CAGR, 2024 - 2030
8.9%
Report Coverage
Worldwide

Global drug device combination products market, 2018-2030 (US$M)

Related Markets

Global drug device combination products market highlights

  • The global drug device combination products market generated a revenue of USD 138,476.4 million in 2023 and is expected to reach USD 251,872.3 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 8.9% by 2030.
  • In terms of segment, transdermal patches accounted for a revenue of USD 31,957.4 million in 2023.
  • Drug Eluting Stents is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Thailand is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 138,476.4 million
Market revenue in 2030USD 251,872.3 million
Growth rate8.9% (CAGR from 2023 to 2030)
Largest segmentTransdermal patches
Fastest growing segmentDrug Eluting Stents
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhotodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters

Other key industry trends

  • In terms of revenue, the North America accounted for 41.3% of the global drug device combination products market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Thailand is the fastest growing regional market and is projected to reach USD 2,316.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Device Combination Products Market Companies

Name Profile # Employees HQ Website

Global drug device combination products market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.


Transdermal patches was the largest segment with a revenue share of 23.08% in 2023. Horizon Databook has segmented the Global drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Drug Device Combination Products Product Outlook (Revenue, USD Million, 2018-2030)
    • Photodynamic Therapy Devices
    • Transdermal Patches
    • Wound Care Products
    • Others
    • Infusion Pumps
      • Volumetric
      • Disposables
      • Syringes
      • Ambulatory
      • Implantable
      • Insulin
    • Orthopedic Combination Products
      • Bone Graft Implants
      • Antibiotic Bone Cement
    • Drug Eluting Stents
      • Coronary Stents
      • Peripheral Vascular Stents
    • Inhalers
      • Dry Powder
      • Nebulizers
      • Metered Dose
    • Antimicrobial Catheters
      • Urological
      • Cardiovascular
      • Others

Reasons to subscribe to Global drug device combination products market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global drug device combination products market databook

  • Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global drug device combination products market , including forecasts for subscribers. This global databook contains high-level insights into Global drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global drug device combination products market size, by regions, 2018-2030 (US$M)

Top 10 countries: Drug device combination products market size, 2023 (US$M)

Global drug device combination products market share, by product, 2023 & 2030 (%, US$M)

Drug device combination products market: Opportunity assessment by country

Global drug device combination products market, by region, 2023 (US$M)

Global drug device combination products market size, by regions, 2018-2030 (US$M)

Product 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 47,893.3 51,287.3 44,320.5 49,506.2 53,182.3 57,204.6 61,609.9 66,439.3 71,738.6 77,559.2 83,958.5 91,001.1 98,759.2 8.1%
Europe 30,385.0 32,973.0 28,875.0 32,685.2 35,582.6 38,787.2 42,335.2 46,267.6 50,630.7 55,476.8 60,865.2 66,863.1 73,546.7 9.6%
Asia Pacific 26,256.9 28,593.5 25,126.5 28,539.0 31,173.2 34,092.9 37,332.5 40,930.9 44,932.1 49,385.7 54,348.5 59,884.3 66,066.1 9.9%
Latin America 4,855.4 5,139.6 4,389.0 4,843.1 5,138.0 5,456.0 5,798.9 6,169.0 6,568.5 6,999.9 7,465.8 7,969.2 8,513.3 6.6%
MEA 2,483.6 2,654.2 2,289.0 2,551.5 2,735.1 2,935.7 3,154.9 3,394.6 3,657.1 3,944.7 4,260.1 4,606.5 4,987.1 7.9%
Overall 111,874.2 120,647.5 105,000.0 118,125.0 127,811.2 138,476.4 150,231.5 163,201.4 177,526.9 193,366.3 210,898.1 230,324.2 251,872.3 8.9%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more